TCMD
TACTILE SYSTEMS TECHNOLOGY INC
NASDAQ · Healthcare · Medical - Devices · US
$27.18
+9.69%Year over year
Reported trailing growth
- Revenue
- +14.4%
- EBITDA
- +14.9%
- EBIT
- +46.2%
- EPS
- +36.4%
- Free cash flow
- -26.5%
- Operating cash flow
- -23.1%
Forward estimates
Based on analyst estimates
- Revenue
- +8.1%
- EBITDA
- +0.6%
- EPS
- +22.5%
Three-year CAGR
- Revenue
- +10.1%
- EBITDA
- +21.5%
- EBIT
- +27.4%
- Net income
- -18.2%
- EPS
- -18.2%
- Free cash flow
- +130.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026